An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Mannatech Announces Results of Annual Shareholders’ Meeting
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Mannatech, a global health and wellness company, announced the successful passage of all shareholder proposals during its annual meeting on June 14, 2022. Notable outcomes included the election of J. Stanley Fredrick and Tyler Rameson as Class II Directors, with 66.5% of shares represented. Additionally, shareholders ratified BDO USA, LLP as independent auditors for the fiscal year ending December 31, 2022, and approved the compensation for Mannatech's named executive officers. The company emphasizes its commitment to transforming lives through high-quality nutritional products.
Positive
Shareholders passed all proposals at the annual meeting.
J. Stanley Fredrick and Tyler Rameson elected as Class II Directors until 2025.
BDO USA, LLP ratified as independent auditors for 2022.
Compensation for named executive officers received shareholder approval.
Negative
None.
FLOWER MOUND, Texas--(BUSINESS WIRE)--
Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech’s annual shareholder meeting (the "Meeting") held Tuesday, June 14, 2022.
Mannatech’s Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech’s Chief Financial Officer, spoke to the shareholders sharing the company’s financial results for 2021 and the first quarter of 2022.
There were 1,949,716 outstanding shares of Mannatech’s common stock as of April 14, 2022 entitled to vote and 1,295,936 shares, or approximately 66.5% represented at the Meeting, either in person or by proxy.
The following matters were submitted and voted upon at the Meeting:
1. Mannatech shareholders voted on the election of two individual to the Board of Directors as Class II Directors to hold office until 2025 as set forth below:
Name
Number of Shares
For
Number of Shares
Withheld
Broker
Non-Votes
J. Stanley Fredrick
926,727
9,438
359,771
Tyler Rameson
775,361
160,804
359,771
2. Mannatech shareholders voted to ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2022 as set forth below:
Number of Shares
For
Number of Shares
Against
Number of Shares
Abstaining
1,289,007
3,335
3,594
3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech’s named executive officers as set forth below:
Number of Shares
For
Number of Shares
Against
Number of Shares
Abstaining
Broker
Non-Votes
929,059
2,761
4,345
359,771
To begin improving your life and the lives of those around you, please visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit Mannatech.com.
^Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.
Please Note: This release contains “forward-looking statements.” These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the SEC and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's ability to complete the anticipated tender offer in a timely manner or at all, the price at which shares of the Company's common stock may trade on Nasdaq, which may be higher or lower than the purchase price in the anticipated tender offer, uncertainty as to the number of shares purchased in the tender offer, the impact of the outbreak of the novel coronavirus ("COVID-19") pandemic, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the SEC, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.